Breaking News Instant updates and real-time market news.

KIQ

Kelso Technologies

$0.50 /

-0.04 (-7.41%)

09:13
04/02/20
04/02
09:13
04/02/20
09:13

Kelso Technologies says pandemic has no impact on ability to continue operations

Kelso Technologies reports that while certain government authorities in North America have ordered the closure or minimization of all non-essential business operations in various regions, the Company falls within the exemptions for businesses that provide essential products and workforces that carry out critical manufacturing. Kelso therefore plans to continue operations at the Company's valve assembly facility in Bonham, Texas while being mindful of the potential impacts of COVID-19 given current conditions. The Company carries out essential services as a producer and reliable supplier of specialized rail tank car service equipment necessary for the safe operation and maintenance of rail tank car transportation systems. As a producer of specialized valves used in the transport of hazardous commodities, the Company's products remain crucial for the safe delivery of hazardous materials by rail transport in North America as they can mitigate the negative impacts of human error and environmental harm. The Company continues to be committed to the health and safety of Kelso's employees, business partners and communities where we operate. The Company is applying comprehensive and rigorous hygiene policies and employee temperature monitoring practices to lower the risk. Travel is restricted and the Company's personnel who can work from home do so. Management is maintaining full adherence to measures put in place by applicable government authorities. The Company's working capital was $7,937,873 at December 31, 2019 and sales in the first quarter 2020 are comparable to the first quarter in 2019. The pandemic has had no negative impact on the Company's working capital and Kelso's ability to continue business operations. The Company has no interest-bearing long-term debt and currently operates without the need for new equity capital, credit facilities or government assistance. The Company will continue to finance operations and research and development from existing capital reserves and product sales.

TODAY'S FREE FLY STORIES

Downgrade
Wartsila downgraded to Underweight from Neutral at JPMorgan » 05:19
10/26/20
10/26
05:19
10/26/20
05:19
WRTBY

Wartsila

$0.00 /

+ (+0.00%)

JPMorgan analyst Andreas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WRTBY Wartsila
$0.00 /

+ (+0.00%)

10/13/20 Goldman Sachs
Wartsila downgraded to Neutral from Buy at Goldman Sachs
10/13/20 Pareto
Wartsila upgraded to Buy from Hold at Pareto
10/02/20 JPMorgan
Wartsila price target lowered to EUR 7 from EUR 7.50 at JPMorgan
08/07/20 RBC Capital
Wartsila downgraded to Underperform from Sector Perform at RBC Capital
Hot Stocks
Elbit Systems to report $60M in non-cash expenses related to COVID-19 in Q3 » 05:15
10/26/20
10/26
05:15
10/26/20
05:15
ESLT

Elbit Systems

$119.03 /

-0.6 (-0.50%)

Elbit Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESLT Elbit Systems
$119.03 /

-0.6 (-0.50%)

ESLT Elbit Systems
$119.03 /

-0.6 (-0.50%)

01/27/20 Jefferies
Jefferies starts Elbit Systems at Buy with $185 price target
01/27/20 Jefferies
Elbit Systems initiated with a Buy at Jefferies
Upgrade
First Solar upgraded to Buy from Neutral at Roth Capital » 05:14
10/26/20
10/26
05:14
10/26/20
05:14
FSLR

First Solar

$85.40 /

+2.71 (+3.28%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
$85.40 /

+2.71 (+3.28%)

FSLR First Solar
$85.40 /

+2.71 (+3.28%)

05:01 Today Credit Suisse
First Solar downgraded to Underperform from Neutral at Credit Suisse
10/22/20 Baird
Baird a buyer of solar stocks insulated from supply chain disruptions
10/20/20 JMP Securities
First Solar price target raised to $100 from $91 at JMP Securities
10/16/20 BofA
First Solar downgraded to Neutral from Buy at BofA
FSLR First Solar
$85.40 /

+2.71 (+3.28%)

  • 17
    Sep
FSLR First Solar
$85.40 /

+2.71 (+3.28%)

FSLR First Solar
$85.40 /

+2.71 (+3.28%)

Initiation
Palantir initiated with a Buy at Jefferies » 05:13
10/26/20
10/26
05:13
10/26/20
05:13
PLTR

Palantir

$9.49 /

-0.195 (-2.01%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$9.49 /

-0.195 (-2.01%)

PLTR Palantir
$9.49 /

-0.195 (-2.01%)

05:10 Today Goldman Sachs
Palantir initiated with a Neutral at Goldman Sachs
PLTR Palantir
$9.49 /

-0.195 (-2.01%)

PLTR Palantir
$9.49 /

-0.195 (-2.01%)

PLTR Palantir
$9.49 /

-0.195 (-2.01%)

PLTR Palantir
$9.49 /

-0.195 (-2.01%)

Initiation
Asana initiated with a Buy at Jefferies » 05:12
10/26/20
10/26
05:12
10/26/20
05:12
ASAN

Asana

$23.51 /

-0.48 (-2.00%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

10/08/20 Bernstein
Asana initiated with an Underperform at Bernstein
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

Initiation
Palantir initiated with a Neutral at Goldman Sachs » 05:10
10/26/20
10/26
05:10
10/26/20
05:10
PLTR

Palantir

$9.49 /

-0.195 (-2.01%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$9.49 /

-0.195 (-2.01%)

PLTR Palantir
$9.49 /

-0.195 (-2.01%)

PLTR Palantir
$9.49 /

-0.195 (-2.01%)

PLTR Palantir
$9.49 /

-0.195 (-2.01%)

PLTR Palantir
$9.49 /

-0.195 (-2.01%)

Recommendations
Zendesk price target raised to $130 from $113 at Oppenheimer » 05:09
10/26/20
10/26
05:09
10/26/20
05:09
ZEN

Zendesk

$110.27 /

+1.56 (+1.44%)

Oppenheimer analyst Koji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZEN Zendesk
$110.27 /

+1.56 (+1.44%)

ZEN Zendesk
$110.27 /

+1.56 (+1.44%)

10/13/20 RBC Capital
Zendesk price target raised to $130 from $110 at RBC Capital
09/01/20
Fly Intel: Top five analyst upgrades
09/01/20 Piper Sandler
Zendesk upgraded to Overweight from Neutral at Piper Sandler
07/31/20 RBC Capital
Zendesk price target lowered to $110 from $120 at RBC Capital
ZEN Zendesk
$110.27 /

+1.56 (+1.44%)

ZEN Zendesk
$110.27 /

+1.56 (+1.44%)

Hot Stocks
STMicroelectronics, Sanken Electric collaborate on IPM equipment designs » 05:08
10/26/20
10/26
05:08
10/26/20
05:08
STM

STMicroelectronics

$34.00 /

+0.23 (+0.68%)

STMicroelectronics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STM STMicroelectronics
$34.00 /

+0.23 (+0.68%)

STM STMicroelectronics
$34.00 /

+0.23 (+0.68%)

10/23/20 Barclays
STMicroelectronics price target raised to EUR 36 from EUR 34 at Barclays
10/23/20 Deutsche Bank
STMicroelectronics price target raised to EUR 36 from EUR 34 at Deutsche Bank
10/23/20 JPMorgan
STMicroelectronics price target raised to EUR 32 from EUR 30 at JPMorgan
10/23/20 Morgan Stanley
STMicroelectronics price target raised to EUR 32.50 at Morgan Stanley
STM STMicroelectronics
$34.00 /

+0.23 (+0.68%)

STM STMicroelectronics
$34.00 /

+0.23 (+0.68%)

STM STMicroelectronics
$34.00 /

+0.23 (+0.68%)

STM STMicroelectronics
$34.00 /

+0.23 (+0.68%)

Recommendations
Mirati Therapeutics price target raised to $210 from $170 at Piper Sandler » 05:07
10/26/20
10/26
05:07
10/26/20
05:07
MRTX

Mirati Therapeutics

$180.37 /

+0.13 (+0.07%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

05:05 Today Piper Sandler
Amgen opportunity not diminished by Mirati data, says Piper Sandler
10/21/20 BMO Capital
Mirati Therapeutics price target raised to $176 from $101 at BMO Capital
10/08/20 Credit Suisse
Mirati Therapeutics price target raised to $190 from $140 at Credit Suisse
09/28/20 BofA
Mirati Therapeutics initiated with a Neutral at BofA
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

  • 10
    Jan
Recommendations
Amgen opportunity not diminished by Mirati data, says Piper Sandler » 05:05
10/26/20
10/26
05:05
10/26/20
05:05
AMGN

Amgen

$227.06 /

-0.84 (-0.37%)

, MRTX

Mirati Therapeutics

$180.37 /

+0.13 (+0.07%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$227.06 /

-0.84 (-0.37%)

MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

05:00 Today Raymond James
Amgen upgraded to Outperform from Market Perform at Raymond James
10/22/20 Oppenheimer
Amgen price target lowered to $275 from $280 at Oppenheimer
10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Truist
Amgen downgraded to Hold from Buy at Truist
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

10/21/20 BMO Capital
Mirati Therapeutics price target raised to $176 from $101 at BMO Capital
10/08/20 Credit Suisse
Mirati Therapeutics price target raised to $190 from $140 at Credit Suisse
09/28/20 BofA
Mirati Therapeutics initiated with a Neutral at BofA
09/28/20 BofA
Mirati Therapeutics initiated with a Neutral at BofA
AMGN Amgen
$227.06 /

-0.84 (-0.37%)

MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

  • 10
    Jan
AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

General news
FX Update: The dollar is firmer » 05:05
10/26/20
10/26
05:05
10/26/20
05:05

FX Update: The dollar is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
First Solar downgraded to Underperform from Neutral at Credit Suisse » 05:01
10/26/20
10/26
05:01
10/26/20
05:01
FSLR

First Solar

$85.40 /

+2.71 (+3.28%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
$85.40 /

+2.71 (+3.28%)

FSLR First Solar
$85.40 /

+2.71 (+3.28%)

10/22/20 Baird
Baird a buyer of solar stocks insulated from supply chain disruptions
10/20/20 JMP Securities
First Solar price target raised to $100 from $91 at JMP Securities
10/16/20 BofA
First Solar downgraded to Neutral from Buy at BofA
10/16/20 BofA
First Solar downgraded to Neutral from Buy at BofA
FSLR First Solar
$85.40 /

+2.71 (+3.28%)

  • 17
    Sep
FSLR First Solar
$85.40 /

+2.71 (+3.28%)

FSLR First Solar
$85.40 /

+2.71 (+3.28%)

Downgrade
SunPower downgraded to Neutral from Outperform at Credit Suisse » 05:01
10/26/20
10/26
05:01
10/26/20
05:01
SPWR

SunPower

$16.86 /

+0.48 (+2.93%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPWR SunPower
$16.86 /

+0.48 (+2.93%)

SPWR SunPower
$16.86 /

+0.48 (+2.93%)

10/22/20 Baird
Baird a buyer of solar stocks insulated from supply chain disruptions
10/07/20
Fly Intel: Top five analyst initiations
10/07/20 Piper Sandler
SunPower initiated with an Overweight at Piper Sandler
10/06/20 GLJ Research
SunPower upgraded to Buy from Sell at GLJ Research
SPWR SunPower
$16.86 /

+0.48 (+2.93%)

  • 21
    Nov
SPWR SunPower
$16.86 /

+0.48 (+2.93%)

SPWR SunPower
$16.86 /

+0.48 (+2.93%)

Upgrade
Amgen upgraded to Outperform from Market Perform at Raymond James » 05:00
10/26/20
10/26
05:00
10/26/20
05:00
AMGN

Amgen

$227.06 /

-0.84 (-0.37%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

10/22/20 Oppenheimer
Amgen price target lowered to $275 from $280 at Oppenheimer
10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Truist
Amgen downgraded to Hold from Buy at Truist
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

Upgrade
Toll Brothers upgraded to Outperform from Market Perform at Raymond James » 04:58
10/26/20
10/26
04:58
10/26/20
04:58
TOL

Toll Brothers

$47.27 /

+1.485 (+3.24%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$47.27 /

+1.485 (+3.24%)

TOL Toll Brothers
$47.27 /

+1.485 (+3.24%)

10/08/20 JPMorgan
Toll Brothers price target raised to $50 from $36.50 at JPMorgan
09/22/20 Barclays
Toll Brothers price target raised to $45 from $43 at Barclays
08/27/20 BTIG
Toll Brothers price target raised to $36 from $27 at BTIG
08/27/20 Barclays
Toll Brothers price target raised to $43 from $29 at Barclays
TOL Toll Brothers
$47.27 /

+1.485 (+3.24%)

TOL Toll Brothers
$47.27 /

+1.485 (+3.24%)

TOL Toll Brothers
$47.27 /

+1.485 (+3.24%)

TOL Toll Brothers
$47.27 /

+1.485 (+3.24%)

Upgrade
D.R. Horton upgraded to Outperform from Market Perform at Raymond James » 04:57
10/26/20
10/26
04:57
10/26/20
04:57
DHI

D.R. Horton

$73.05 /

+2.46 (+3.48%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DHI D.R. Horton
$73.05 /

+2.46 (+3.48%)

DHI D.R. Horton
$73.05 /

+2.46 (+3.48%)

10/16/20 BTIG
BTIG raises price targets among select Homebuilding names
10/08/20 JPMorgan
D.R. Horton price target raised to $90 from $73 at JPMorgan
09/17/20 Barclays
D.R. Horton price target raised to $81 from $73 at Barclays
09/03/20 Credit Suisse
D.R. Horton price target raised to $84 from $77 at Credit Suisse
DHI D.R. Horton
$73.05 /

+2.46 (+3.48%)

DHI D.R. Horton
$73.05 /

+2.46 (+3.48%)

DHI D.R. Horton
$73.05 /

+2.46 (+3.48%)

Upgrade
PulteGroup upgraded to Strong Buy from Outperform at Raymond James » 04:57
10/26/20
10/26
04:57
10/26/20
04:57
PHM

PulteGroup

$43.99 /

+1.35 (+3.17%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHM PulteGroup
$43.99 /

+1.35 (+3.17%)

PHM PulteGroup
$43.99 /

+1.35 (+3.17%)

10/23/20 Susquehanna
PulteGroup upgraded to Positive at Susquehanna
10/23/20 RBC Capital
PulteGroup upgraded to Outperform from Sector Perform at RBC Capital
10/23/20 Susquehanna
PulteGroup upgraded to Positive from Neutral at Susquehanna
10/23/20 RBC Capital
PulteGroup upgraded to Outperform from Sector Perform at RBC Capital
PHM PulteGroup
$43.99 /

+1.35 (+3.17%)

PHM PulteGroup
$43.99 /

+1.35 (+3.17%)

PHM PulteGroup
$43.99 /

+1.35 (+3.17%)

PHM PulteGroup
$43.99 /

+1.35 (+3.17%)

Upgrade
First Midwest upgraded to Outperform from Market Perform at Raymond James » 04:56
10/26/20
10/26
04:56
10/26/20
04:56
FMBI

First Midwest

$12.59 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMBI First Midwest
$12.59 /

+ (+0.00%)

FMBI First Midwest
$12.59 /

+ (+0.00%)

03/06/20 SunTrust
First Midwest downgraded to Hold from Buy at SunTrust
FMBI First Midwest
$12.59 /

+ (+0.00%)

Upgrade
Crown Castle upgraded to Outperform from Market Perform at Raymond James » 04:55
10/26/20
10/26
04:55
10/26/20
04:55
CCI

Crown Castle

$158.54 /

+2.285 (+1.46%)

Raymond James analyst Ric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

08/20/20
Fly Intel: Top five analyst downgrades
08/20/20 Wells Fargo
Wells Fargo downgrades Crown Castle on fiber, 2020 guidance risk
08/20/20 Wells Fargo
Crown Castle downgraded to Equal Weight from Overweight at Wells Fargo
07/15/20 Barclays
Crown Castle initiated with an Overweight at Barclays
CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

General news
3-Month Bill Auction to be released at 11:30  04:55
10/26/20
10/26
04:55
10/26/20
04:55
 
Conference/Events
Truist gaming analysts to hold an analyst/industry conference call » 04:55
10/26/20
10/26
04:55
10/26/20
04:55

Analysts, along with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Jazz Pharmaceuticals to hold an investor update conference call » 04:55
10/26/20
10/26
04:55
10/26/20
04:55
JAZZ

Jazz Pharmaceuticals

$150.09 /

-1.21 (-0.80%)

Management provides an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$150.09 /

-1.21 (-0.80%)

JAZZ Jazz Pharmaceuticals
$150.09 /

-1.21 (-0.80%)

10/22/20 BofA
Jazz Pharmaceuticals added to US 1 List at BofA
10/20/20 Truist
Jazz Pharmaceuticals price target raised to $175 from $157 at Truist
10/09/20 Jefferies
Jazz Pharmaceuticals price target raised to $188 from $151 at Jefferies
09/14/20
Fly Intel: Top five analyst downgrades
JAZZ Jazz Pharmaceuticals
$150.09 /

-1.21 (-0.80%)

JAZZ Jazz Pharmaceuticals
$150.09 /

-1.21 (-0.80%)

Conference/Events
Aileron Therapeutics to host conference call » 04:55
10/26/20
10/26
04:55
10/26/20
04:55
ALRN

Aileron Therapeutics

$1.92 /

-0.19 (-9.00%)

Management will discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

06/05/20 H.C. Wainwright
Aileron Therapeutics price target lowered to $2 from $3 at H.C. Wainwright
05/27/20 JonesTrading
JonesTrading sees potential positive myelopreservation data in June for Aileron
04/08/20 JonesTrading
Aileron Therapeutics initiated with a Buy at JonesTrading
04/08/20 JonesTrading
Aileron Therapeutics initiated with a Buy at JonesTrading
ALRN Aileron Therapeutics
$1.92 /

-0.19 (-9.00%)

  • 04
    Jun
Conference/Events
Cantor Fitzgerald pharmaceuticals analysts hold analyst/industry conference call » 04:55
10/26/20
10/26
04:55
10/26/20
04:55
MRTX

Mirati Therapeutics

$180.37 /

+0.13 (+0.07%)

Pharmaceuticals Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

10/21/20 BMO Capital
Mirati Therapeutics price target raised to $176 from $101 at BMO Capital
10/08/20 Credit Suisse
Mirati Therapeutics price target raised to $190 from $140 at Credit Suisse
09/28/20 BofA
Mirati Therapeutics initiated with a Neutral at BofA
09/28/20 BofA
Mirati Therapeutics initiated with a Neutral at BofA
MRTX Mirati Therapeutics
$180.37 /

+0.13 (+0.07%)

  • 10
    Jan
Conference/Events
Exelixis participates in a conference call with Cowen » 04:55
10/26/20
10/26
04:55
10/26/20
04:55
EXEL

Exelixis

$22.31 /

+0.46 (+2.11%)

Healthcare Analyst Werber…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
05/14/20 SunTrust
Exelixis price target raised to $40 from $35 at SunTrust
EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

EXEL Exelixis
$22.31 /

+0.46 (+2.11%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.